Preparation, characterization and in vitro evaluation of atorvastatin nanosuspensions
PLOS One · 21.10.2025 · 20 (10) · e0335024
DOI: 10.1371/journal.pone.0335024 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 21.10.2025. Verfasst von Yaman Ahmad Akour und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences and Pharmaceutics, Faculty of Pharmacy, Applied Science Private University, Amman, Jordan. Hauptthemen laut MEDLINE: Atorvastatin, Nanoparticles. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Applied Science Private University.
Abstract (Originalsprache)
Poorly water-soluble drugs present a significant challenge for pharmaceutical development, particularly affecting the pharmacokinetics of orally administered drugs due to their poor dissolution. This study aimed to enhance the dissolution of a low water solubility drug atorvastatin using nanosuspension technology. Antisolvent technique was utilized to prepare atorvastatin calcium nanosuspensions. Different stabilizers were used including Cremophor, HPMC, pluronics (F127, F108, and F68), PEG400, PEG600, PEG 1k, PEG8k, PVA, PVP k30, PVP k10, PVP 44k, SLS, sodium alginate, Tween 20, and Tween 80. The prepared nanosuspensions were lyophilized using mannitol or trehalose as a lyoprotectant. Several optimum formulations were obtained. The selected best optimum formulation was 2% pluronic F127, 80 mg mannitol, and 2 min sonication time. It exhibited a mean particle size of 54.5 nm, a zeta potential of −0.809, and 0.141 PDI after reconstitution. The crystalline state of the nanoparticles was evaluated using differential scanning calorimetry (DSC) and X-ray diffraction (XRD). Fourier-transform infrared spectroscopy (FTIR) was used to assess interactions between the drug substance and the additives. In vitro drug release study was conducted for lyophilized nanosuspension in comparison to the innovator product Lipitor® in two different media, 0.05M potassium phosphate buffer pH 6.8 and 0.1N HCL. The XRD analyses indicated that the lyophilized nanosuspension was partially crystalline with some amorphization and this confirmed by DSC. FTIR results suggested that there was a physical interaction between atorvastatin and the additives. The polymer and lyoprotectant successfully preserved and coated the drug nanoparticles. The lyophilized nanosuspension exhibited superior dissolution in 0.1N HCl. However, the innovator was faster in 0.05 M phosphate buffer. In conclusion, successful preparation of lyophilized nanosuspension of atorvastatin calcium was achieved. The current findings revealed that excipient functionality in terms of stabilization, effect on solid state properties, and drug release were critical for development of stable and efficient nanosuspension.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences and Pharmaceutics, Faculty of Pharmacy, Applied Science Private University, Amman, Jordan.
- Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, The Hashemite University, Zarqa, Jordan.
ORCID-Profile: Eman M Migdadi
Förderung
- Applied Science Private University
Zitieren
APA
Akour, Y. A., Aljaberi, A., Hamed, S. H., Altaher, A., & Migdadi, E. M. (2025). Preparation, characterization and in vitro evaluation of atorvastatin nanosuspensions. PLOS One, 20(10), e0335024. https://doi.org/10.1371/journal.pone.0335024
Vancouver
Akour YA, Aljaberi A, Hamed SH, Altaher A, Migdadi EM. Preparation, characterization and in vitro evaluation of atorvastatin nanosuspensions. PLOS One. 2025;20(10):e0335024. doi:10.1371/journal.pone.0335024
BibTeX
@article{Akour2025,
author = {Akour, Yaman Ahmad and Aljaberi, Ahmad and Hamed, Saja H and Altaher, Alaa and Migdadi, Eman M},
title = {Preparation, characterization and in vitro evaluation of atorvastatin nanosuspensions},
journal = {PLOS One},
year = {2025},
volume = {20},
number = {10},
pages = {e0335024},
doi = {10.1371/journal.pone.0335024}
}
EUVIMED